Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-30

Clinical Trial Update: IMPACT EU Post-Market Clinical Follow-Up Study [NA]

View source ↗

Summary

Clinical trial update for Abiomed's IMPACT EU post-market clinical follow-up study in patients with left ventricular dysfunction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Impella (Impella microaxial pump)

Snippet

Sponsor: Abiomed Inc. | Conditions: Left Ventricular Dysfunction | NA | Status: ACTIVE_NOT_RECRUITING